O. Ménard

636 total citations
30 papers, 372 citations indexed

About

O. Ménard is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, O. Ménard has authored 30 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in O. Ménard's work include Medical Imaging and Pathology Studies (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Pleural and Pulmonary Diseases (3 papers). O. Ménard is often cited by papers focused on Medical Imaging and Pathology Studies (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Pleural and Pulmonary Diseases (3 papers). O. Ménard collaborates with scholars based in France, Switzerland and Germany. O. Ménard's co-authors include Y. Martinet, Pierre Vaillant, J Vignaud, Nadine Martinet, J. Bignon, N Massin, Yuriko Iwatsubo, Jean‐Claude Pairon, C Boutin and D. Caillaud and has published in prestigious journals such as American Journal of Epidemiology, European Respiratory Journal and Histopathology.

In The Last Decade

O. Ménard

29 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Ménard France 7 223 63 55 49 46 30 372
Dawn Gano United States 18 298 1.3× 51 0.8× 106 1.9× 62 1.3× 48 1.0× 58 836
Kosuke Sakurai Japan 14 68 0.3× 25 0.4× 34 0.6× 13 0.3× 79 1.7× 28 510
Anderson H. Kuo United States 14 172 0.8× 23 0.4× 9 0.2× 22 0.4× 101 2.2× 30 477
Jonathan Drake United States 8 88 0.4× 51 0.8× 39 0.7× 40 0.8× 15 0.3× 27 385
Sarah Cross United States 12 46 0.2× 110 1.7× 21 0.4× 44 0.9× 41 0.9× 34 437
Gamze Çapa Kaya Türkiye 15 206 0.9× 16 0.3× 68 1.2× 59 1.2× 69 1.5× 73 616
Carin Stenlund Sweden 9 53 0.2× 53 0.8× 7 0.1× 28 0.6× 19 0.4× 11 550
Anneli Påhlson Sweden 8 43 0.2× 61 1.0× 9 0.2× 49 1.0× 10 0.2× 8 682
Jonathan Wilson United States 4 336 1.5× 9 0.1× 28 0.5× 44 0.9× 13 0.3× 5 474
Oliver Neumann Germany 9 77 0.3× 39 0.6× 30 0.5× 28 0.6× 73 1.6× 12 574

Countries citing papers authored by O. Ménard

Since Specialization
Citations

This map shows the geographic impact of O. Ménard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Ménard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Ménard more than expected).

Fields of papers citing papers by O. Ménard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Ménard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Ménard. The network helps show where O. Ménard may publish in the future.

Co-authorship network of co-authors of O. Ménard

This figure shows the co-authorship network connecting the top 25 collaborators of O. Ménard. A scholar is included among the top collaborators of O. Ménard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Ménard. O. Ménard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weibel, Sébastien, O. Ménard, Jean‐Arthur Micoulaud‐Franchi, et al.. (2019). Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. L Encéphale. 46(1). 30–40. 67 indexed citations
2.
Tiotiu, Angélica, et al.. (2019). Stratégies thérapeutiques dans le cancer bronchique non à petites cellules ALK positif de stade IV. Revue des Maladies Respiratoires. 36(10). 1107–1116. 3 indexed citations
3.
Paillot, N., et al.. (2019). Facteurs prédictifs de survenue d’évènements osseux dans le cancer bronchique. Revue des Maladies Respiratoires. 37(2). 111–116. 1 indexed citations
4.
Dondaine, Thibaut, Christelle Marquié, David Devos, et al.. (2018). Prescriptions hors AMM supervisées de méthylphénidate dans le TDAH de l’adulte. L Encéphale. 45(1). 74–81. 3 indexed citations
5.
Ménard, O., Damien Mandry, Joëlle Siat, et al.. (2017). Hypoglycémie paranéoplasique : les espoirs d’une documentation physiopathologique. Revue de Pneumologie Clinique. 73(3). 140–145. 2 indexed citations
6.
Ménard, O., et al.. (2016). Épidémiologie des calculs urinaires dans le Sud de la France : étude rétrospective monocentrique. Progrès en Urologie. 26(6). 339–345. 5 indexed citations
7.
Hérin, Fabrice, et al.. (2011). A 38-year-old hairdresser with irritant-associated vocal cord dysfunction [Case study]. The International Journal of Tuberculosis and Lung Disease. 16(1). 138–139. 6 indexed citations
8.
Astoul, P. & O. Ménard. (2006). 2.1 Quels critères diagnostiques pour le mésothéliome pleural malin (MPM) ?. Revue des Maladies Respiratoires. 23(4). 29–35. 4 indexed citations
9.
Peiffert, D., et al.. (2000). La curiethérapie endobronchique de haut débit de dose: un traitement curatif. Cancer/Radiothérapie. 4(3). 197–201. 4 indexed citations
10.
Iwatsubo, Yuriko, Jean‐Claude Pairon, C Boutin, et al.. (1998). Pleural Mesothelioma: Dose-Response Relation at Low Levels of Asbestos Exposure in a French Population-based Case-Control Study. American Journal of Epidemiology. 148(2). 133–142. 108 indexed citations
11.
Martinet, Y., et al.. (1998). Chemoprevention for lung cancer. Lung Cancer. 21. S5–S6. 2 indexed citations
12.
Labouyrie, Eric, et al.. (1997). Human immunodeficiency virus type 1 in an unusual cystic lymphoepithelial lesion of the lung. Histopathology. 31(1). 83–86. 3 indexed citations
13.
Vaillant, Pierre, O. Ménard, J Vignaud, Nadine Martinet, & Y. Martinet. (1996). The role of cytokines in human lung fibrosis.. PubMed. 51(2). 145–52. 60 indexed citations
14.
A’Amar, Ousama M., et al.. (1996). <title>Autofluorescence spectroscopy of normal and malignant tissues: both in-vivo and ex-vivo measurements in the upper aero-digestive tract and lung tissues</title>. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 2679. 42–50. 5 indexed citations
15.
Ménard, O., Nathalie Petit, Pierre Gillet, A Gaucher, & Y. Martinet. (1995). Association of histologically proven rheumatoid arthritis with pulmonary sarcoidosis. European Respiratory Journal. 8(3). 472–473. 19 indexed citations
16.
Ménard, O., et al.. (1992). [Significance of the level of carcinoembryonic antigen in the alveolar lavage fluid in cancerous and non-cancerous bronchopulmonary pathology].. PubMed. 9(2). 185–9. 1 indexed citations
17.
Ménard, O.. (1991). [Atrial natriuretic factor and the lung].. PubMed. 8(2). 153–67. 3 indexed citations
18.
Ménard, O., et al.. (1991). [Muscle metastases of cancers].. PubMed. 142(6). 423–8. 35 indexed citations
19.
Ménard, O., et al.. (1990). [Muscular metastasis of primary bronchial carcinoma].. PubMed. 46(4). 183–6. 5 indexed citations
20.
Ménard, O., et al.. (1987). [Severe pulmonary mycobacteriosis caused by Mycobacterium simiae].. PubMed. 4(6). 327–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026